In vitro biomedical applications of functionalized iron oxide nanoparticles, including those not related to magnetic properties

Contrast Media and Molecular Imaging

Volumn 6, Issue 4, 2011, Pages 236-250

  Burtea, Carmen ^a   Laurent, Sophie ^a   Mahieu, Isabelle ^a   Larbanoix, Lionel ^a   Roch, Alain ^a   Port, Marc ^b   Rousseaux, Olivier ^b   Ballet, Sébastien ^b   Murariu, Oltea ^a   Toubeau, Gérard ^a   Corot, Claire ^b   Vander Elst, Luce ^a   Muller, Robert N ^a  

^a UNIVERSITY OF MONS   (Belgium)

^b Laboratoire Guerbet   (France)

Author keywords

Contrast agents; ELISA; Functionalized iron oxide nanoparticles; Histochemistry; Molecular targeting; MRI; Perls' iron staining; Relaxometry

Indexed keywords

BIOTIN; BISPHOSPHONIC ACID DERIVATIVE; DEXTRAN; STARCH; STREPTAVIDIN; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; DRUG SYNTHESIS; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOCHEMISTRY; IN VITRO STUDY; MOLECULAR IMAGING; MOLECULAR INTERACTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIGENS, CD3; APOPTOSIS; CELL LINE; CONTRAST MEDIA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FERRIC COMPOUNDS; HUMANS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; NANOPARTICLES;

EID: 79957997128     PISSN: 15554309     EISSN: 15554317     Source Type: Journal    
DOI: 10.1002/cmmi.423     Document Type: Article

References (39)

1. Burtea C, Laurent S, Vander Elst L, Muller RN. Contrast agents - magnetic resonance. In Handbook of Experimental Pharmacology, Semmler W, Schwaiger M (eds). Springer: Berlin, 2008; 135-165.
2. Corot C, Robert P, Idée JM, Port M. Recent advances in iron oxide nanocrystal technology for medical imaging. Adv Drug Deliv Rev 2006; 58: 1471-1504.
3. Sosnovik DE, Weissleder R. Emerging concepts in molecular MRI. Curr Opin Biotechnol 2007; 18: 4-10.
4. Yang L, Peng XH, Wang YA, Wang X, Cao Z, Ni C, Karna P, Zhang X, Wood WC, Gao X, Nie S, Mao H. Receptor-targeted nanoparticles for in vivo imaging of breast cancer. Clin Cancer Res 2009; 15: 4722-4732.
5. Bulte JWM, Modo MMJ. Introduction: The emergence of nanoparticles as imaging platform in biomedicine. In Nanoparticles in Biomedical Imaging, Bulte JWM, Modo MMJ (eds). Springer: New York, 2008; 1-5.
6. Laurent S, Forge D, Port M, Roch A, Robic C, Vander Elst L, Muller RN. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 2008; 108: 2064-2110.
7. Boyer C, Whittaker MR, Bulmus V, Liu J, Davis TP. The design and utility of polymer-stabilized iron-oxide nanoparticles for nanomedicine applications. NPG Asia Mater 2010; 2: 23-30.
8. Perez JM, Kaittanis C. Magnetic nanosensors for probing molecular interactions. In Nanoparticles in Biomedical Imaging, Bulte JWM, Modo MMJ (eds). Springer: New York, 2008; 183-197.
9. Perez JM, Josephson L, Weissleder R. Use of magnetic nanoparticles as nanosensors to probe for molecular interactions. Chembiochem 2004; 5: 261-264.
10. Roch A, Muller RN, Gillis P. Theory of proton relaxation induced by superparamagnetic particles. J Chem Phys 1999; 110: 5403-5411.
11. Muller RN, Gillis P, Moiny M, Roch A. Transverse relaxivity of particulate MRI contrast media: from theories to experiments. Magn Reson Med 1991; 222: 178-182.
12. Song Q, Zhang ZJ. Shape control and associated magnetic properties of spinel cobalt ferrite nanocrystals. J Am Chem Soc 2004; 126: 6164-6168.
13. Song Q, Zhang ZJ. Correlation between spin-orbital coupling and the superparamagnetic properties in magnetite and cobalt ferrite spinel nanocrystals. J Phys Chem B 2006; 110: 11205-11209.
14. Bridot JL, Faure AC, Laurent S, Rivière C, Billotey C, Hiba B, Janier M, Josserand V, Coll JL, Elst LV, Muller R, Roux S, Perriat P, Tillement O. Hybrid gadolinium oxide nanoparticles: multimodal contrast agents for in vivo imaging. J Am Chem Soc 2007; 129: 5076-5084.
15. Mornet S, Vasseur S, Grasset F, Duguet E. Magnetic nanoparticle design for medical diagnosis and therapy. J Mater Chem 2004; 14: 2161-2175.
16. Chemla YR, Grossman HL, Poon Y, McDermott R, Stevens R, Alper MD, Clarke J. Ultrasensitive magnetic biosensor for homogeneous immunoassay. Proc Natl Acad Sci USA 2000; 97: 14268-14272.
17. Grossman HL, Myers WR, Vreeland VJ, Bruehl R, Alper MD, Bertozzi CR, Clarke J. Detection of bacteria in suspension by using a superconducting quantum interference device. Proc Natl Acad Sci USA 2004; 101: 129-134.
18. Kriz K, Gehrke J, Kriz D. Advancements toward magneto immunoassays. Biosens Bioelectron 1998; 13: 817-823.
19. Baselt DR, Lee GU, Natesan M, Metzger SW, Sheehan PE, Colton RJ. A biosensor based on magnetoresistance technology. Biosens Bioelectron 1998; 13: 731-739.
20. Edelstein RL, Tamanaha CR, Sheehan PE, Miller MM, Baselt DR, Whitman LJ, Colton RJ. The BARC biosensor applied to the detection of biological warfare agents. Biosens Bioelectron 2000; 14: 805-813.
21. Burtea C, Laurent S, Roch A, Vander Elst L, Muller RN. C-MALISA (Cellular Magnetic-Linked Immunosorbent Assay), a new application of cellular ELISA for MRI. J Inorg Biochem 2005; 99: 1135-1144.
22. Burtea C, Laurent S, Vander Elst L, Muller RN. Highly sensitive streptavidin-based magnetic nanosensors as a useful tool in clinical diagnosis. ESMRMB 2004; e-poster 372; DOI: 10.1594/ESMRMB04/372.
23. Kim GY, Josephson L, Langer R, Cima MJ. Magnetic relaxation switch detection of human chorionic gonadotrophin. Bioconjug Chem 2007; 18: 2024-2028.
24. Colombo M, Ronchi S, Monti D, Corsi F, Trabucchi E, Prosperi D. Femtomolar detection of autoantibodies by magnetic relaxation nanosensors. Anal Biochem 2009; 392: 96-102.
25. Lee H, Sun E, Ham D, Weissleder R. Chip-NMR biosensor for detection and molecular analysis of cells. Nat Med 2008; 14: 869-874.
26. Roch A, Gossuin Y, Muller RN, Gillis P. Superparamagnetic colloid suspensions: water magnetic relaxation and clustering. J Magn Magn Mater 2005; 293: 532-539.
27. Laumonier C, Segers J, Laurent S, Michel A, Coppée F, Belayew A, Elst LV, Muller RN. A new peptidic vector for molecular imaging of apoptosis, identified by phage display technology. J Biomol Screen 2006; 11: 537-545.
28. Burtea C, Laurent S, Lancelot E, Ballet S, Murariu O, Rousseaux O, Port M, Vander Elst L, Corot C, Muller RN. Peptidic targeting of phosphatidylserine for the MRI detection of apoptosis in atherosclerotic plaques. Mol Pharm 2009; 6: 1903-1919.
29. Burtea C, Laurent S, Port M, Lancelot E, Ballet S, Rousseaux O, Toubeau G, Vander Elst L, Corot C, Muller RN. Molecular MRI of VCAM-1 expression in inflammatory lesions using a peptide-vectorized paramagnetic imaging probe. J Med Chem 2009; 52: 4725-4742.
30. Larbanoix L, Burtea C, Laurent S, Van Leuven F, Toubeau G, Vander Elst L, Muller RN. Potential amyloid plaque-specific peptides for the diagnosis of Alzheimer's disease. Neurobiol Aging 2010; 31: 1679-1689. DOI: 10.1016/j.neurobiolaging.2008.09.021.
31. Laumonier C, Laurent S, Roch A, Vander Elst L, Muller RN. Enzymatic titration by relaxometric measurement. 4th Scientific Meeting of the Wallonia Network for Nanotechnologies (NanoWal), ULB, Brussels, 2005.
32. Laumonier C, Laurent S, Roch A, Vander Elst L, Muller RN. Using superparamagnetic particles and relaxometric measurement for enzymatic titration. Workshop on Nanoscience and Nanotechnology, Interreg IIIc, Nancy, France, 2006.
33. Segers J, Laumonier C, Burtea C, Laurent S, Vander Elst L, Muller RN. From phage display to magnetophage, a new tool for magnetic resonance molecular imaging. Bioconjug Chem 2007; 18: 1251-1258.
34. Boutry S, Forge D, Burtea C, Mahieu I, Murariu O, Laurent S, Vander Elst L, Muller RN. How to quantify iron in an aqueous or biological matrix: a technical note. Contrast Media Mol Imag 2009; 4: 299-304.
35. Philibert P, Philibert A, Wang W, Wang A-P, Wang N, Larroque C, Saven JG, Courtête J, Weiss E, Martineau P. A focused antibody library for selecting scFvs expressed at high levels in the cytoplasm. BMC Biotechnol 2007; 7. DOI: 10.1186/1472-6750-7-81.
36. Aravind L, de Souza RF, Iyer LM. Predicted class-I aminoacyl tRNA synthetase-like proteins in non-ribosomal peptide synthesis. Biol Direct 2010; 5. DOI: 10.1186/1745-6150-5-48.
37. Sarikaya M. Biomimetics: Materials fabrication through biology. Proc Natl Acad Sci 1999; 96: 14183-14185.
38. Boutry S, Laurent S, Vander Elst L, Muller RN. Specific E-selectin targeting with a superparamagnetic MRI contrast agent. Contrast Media Mol Imag 2006; 1: 15-22.
39. Port M, Corot C, Raynal I, Rousseaux O. US Patent 2004/0253181 A1.